Who Owns Tempest Therapeutics Stock?
NASDAQ: TPSTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 27.98%
- Held by insiders
- 30.07%
- Institutional holders
- 23
- Institutions 28.0%
- Insiders 30.1%
- Public and other 42.0%
Who owns Tempest Therapeutics stock?
Institutional investors own about 28.0% of Tempest Therapeutics's shares, spread across 23 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 30.07% of TPST.
The largest institutional holders are Sabby Management, LLC (3.03%), Versant Venture Management, LLC (1.60%) and Vanguard Capital Management LLC (1.38%). Together, the top 10 institutions control 7.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their TPST positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TPST
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Sabby Management, LLC | 511.29K | 3.03% | +2763.4% |
| Versant Venture Management, LLC | 269.77K | 1.60% | 0.0% |
| Vanguard Capital Management LLC | 233.89K | 1.38% | 0.0% |
| Geode Capital Management, LLC | 86.63K | 0.51% | -0.4% |
| Vanguard Fiduciary Trust Co | 68.91K | 0.41% | 0.0% |
| Blackrock Inc. | 39.07K | 0.23% | 0.0% |
| Squarepoint Ops LLC | 30.90K | 0.18% | +100.0% |
| Northern Trust Corporation | 20.14K | 0.12% | +43.3% |
| Citadel Advisors Llc | 19.82K | 0.12% | +100.0% |
| UBS Group AG | 5.64K | 0.03% | +24.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TPST
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 128.94K | 0.76% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 104.94K | 0.62% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 48.45K | 0.29% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 15.68K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 7.50K | 0.04% |
Frequently asked questions
Who is the largest shareholder of Tempest Therapeutics?
Sabby Management, LLC is the largest institutional shareholder of TPST, owning 3.03% of shares outstanding (511.29K shares) as of its latest 13F filing.
What percentage of Tempest Therapeutics is owned by institutions?
Institutions own about 28.0% of TPST shares and 40.0% of the public float.
How much of Tempest Therapeutics do insiders own?
Insiders, such as officers and directors, own about 30.07% of TPST shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.